![Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology](https://oncodaily.com/pub/uploads/2024/04/Снимок-экрана-209-1.png)
Photo generated from www.thelancet.com
Apr 8, 2024, 15:49
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X:
“The TRAIN3 trial of MRI-guided TCHP (3, 6 or 9 cycles) is out in The Lancet Oncology. MRI identified patients with HR-/HER2+ breast cancer having pCR after only 3 cycles of TCHP. May it be MRI, PET, GEP, or ctDNA, the future of treatment for HER2+ eBC will be biomarker driven.”
Read further.
Source: Paolo Tarantino/X